Keyphrases
COVID-19
100%
Finland
48%
Cycle Threshold
30%
Quantitative PCR
26%
Raltegravir
24%
Lymphopenia
24%
NFKB1
24%
Nature-inspired
24%
Tampere
24%
Venous Thromboembolism
24%
IRF2
24%
Protease Inhibitors
24%
Viral Load
24%
Sampling Site
24%
Population-based
24%
Fractional Exhaled Nitric Oxide (FeNO)
24%
Plant Material
24%
Site Comparison
24%
SARS-CoV-2 RT-PCR
24%
Intra-patient
24%
Liver Fat
24%
Immunocompromised Patients
24%
Mild COVID-19
24%
Adipose Tissue
24%
Binding Protein
24%
COVID-19 Infection
24%
Hospital District
24%
Family Members
24%
Immunocompromised Host
24%
Nasal Nitric Oxide
24%
Contact Tracing
24%
Immunomodulatory
24%
Microbiota
24%
Inflammatory Conditions
24%
Tissue Composition
24%
Body Composition Changes
24%
Incomplete Penetrance
24%
Efavirenz
24%
Nasopharynx
22%
Common Variable Immunodeficiency
18%
Acute Infection
18%
Immune Response
16%
Confidence Interval
16%
Nasal Samples
16%
Anterior Nasal Swab
16%
Odds Ratio
16%
Anterior Nasal
16%
High-cycle
16%
Saliva
16%
Nasopharyngeal Swab
16%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
68%
COVID-19
58%
Infection
31%
Efavirenz
24%
Raltegravir
24%
Venous Thromboembolism
24%
Proteinase Inhibitor
24%
Adipose Tissue
24%
Contact Examination
24%
Reverse Transcription Polymerase Chain Reaction
24%
Immunocompromised Patient
24%
Fatty Liver
24%
Odds Ratio
16%
Population Research
11%
Nonalcoholic Fatty Liver
10%
Nose Smear
9%
Nasopharynx
9%
Nasopharyngeal Swab
9%
Virus
9%
Pulmonary Embolism
8%
Nucleic Acid Amplification
8%
Univariate Analysis
8%
Body Weight
6%
Human Immunodeficiency Virus
6%
NMR Spectroscopy
6%
Polymerase Chain Reaction
6%
Adipocyte
6%
Immunology and Microbiology
Lymphocytopenia
24%
Interferon Regulatory Factor 2
24%
Common Variable Immunodeficiency
24%
Viral Load
24%
Protein Binding
24%
COVID-19
24%
STAT1
24%
Microflora
24%
STAT5
24%
Penetrance
24%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
Reverse Transcription Polymerase Chain Reaction
18%
Immune Response
16%
Hypogammaglobulinemia
16%
Probiotic
12%
Normal Human
12%
Microbial Diversity
12%
Immunity
12%
Airway
12%
B Cell
10%
Transcription Factors
8%
Genetic Screening
8%
Light Chain
8%
Prevalence
8%
Enhancer Region
8%
Influenza
6%
Inflammation Response
6%
Respiratory Mucosa
6%
Cycle Threshold
6%
Nasopharynx
6%
Nose
6%